Filing Details
- Accession Number:
- 0001562180-21-001013
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-09 18:05:27
- Reporting Period:
- 2021-02-05
- Accepted Time:
- 2021-02-09 18:05:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1531048 | Inari Medical Inc. | NARI | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1304099 | William Hoffman | C/O Inari Medical, Inc. 9 Parker, Suite 100 Irvine CA 92618 | President And Ceo | No | No | No | No |
Transaction Summary
Sold: | 30,000 shares | Avg. Price: $111.19 | Total Value: $3,335,716.23 |
Number of Shares After Transactions: | 1,111,916 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-02-05 | 1,600 | $107.05 | 1,140,316 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-02-05 | 2,000 | $108.04 | 1,138,316 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-02-05 | 5,792 | $110.36 | 1,132,524 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-02-05 | 16,005 | $111.32 | 1,116,519 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-02-05 | 3,503 | $111.95 | 1,113,016 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-02-05 | 1,100 | $122.97 | 1,111,916 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2020
- This transaction was executed in multiple trades at prices ranging from $106.58 to $107.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $107.67 to $108.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $109.78 to $110.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $110.80 to $111.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $111.80 to $112.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $112.96 to $113.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.